Tianjin Pharmaceutical Da Ren Tang Group Proposes New Independent Director

SGX Filings
04/16

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced that its board, at the third meeting for FY2026 held via teleconference on Apr, 16 2026, approved the proposal to appoint Ms. Zhai Shuping as an independent director for a three-year term.

Ms. Zhai, born in Sep, 1975, holds a Doctorate in Economics from Tianjin University of Finance and Economics and is currently a professor and doctoral supervisor at that university’s School of Accounting. She has previously served as an independent director at Tianjin Great Wall Binhai Automotive Finance Co., Ltd. and Jiangsu Gutian Automation Co., Ltd.

The appointment is subject to shareholders’ approval at the company’s upcoming annual general meeting for the financial year ended Dec, 31 2025.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10